178 related articles for article (PubMed ID: 29899783)
1. Imaging Findings in Maple Syrup Urine Disease: A Case Report.
Kathait AS; Puac P; Castillo M
J Pediatr Neurosci; 2018; 13(1):103-105. PubMed ID: 29899783
[TBL] [Abstract][Full Text] [Related]
2. Brain magnetic resonance imaging findings and radiologic review of maple syrup urine disease: Report of three cases.
Li Y; Liu X; Duan CF; Song XF; Zhuang XH
World J Clin Cases; 2021 Mar; 9(8):1844-1852. PubMed ID: 33748233
[TBL] [Abstract][Full Text] [Related]
3. Imaging in classic form of maple syrup urine disease: a rare metabolic central nervous system.
Jain A; Jagdeesh K; Mane R; Singla S
J Clin Neonatol; 2013 Apr; 2(2):98-100. PubMed ID: 24049754
[TBL] [Abstract][Full Text] [Related]
4. Maple Syrup Urine Disease: An Uncommon Cause of Neonatal Febrile Seizures.
K K H; Ajmera P; Agarwal A; Dahiya A; Parripati VK
Cureus; 2023 Jun; 15(6):e40826. PubMed ID: 37489218
[TBL] [Abstract][Full Text] [Related]
5. Maple syrup urine disease: magnetic resonance imaging findings in three patients.
Allahwala A; Ahmed S; Afroze B
J Pak Med Assoc; 2021 Apr; 71(4):1309-1313. PubMed ID: 34125801
[TBL] [Abstract][Full Text] [Related]
6. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
7. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.
Chiong MA; Tan MA; Cordero CP; Fodra EG; Manliguis JS; Lopez CP; Dalmacio LM
Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412
[TBL] [Abstract][Full Text] [Related]
8. Maple syrup urine disease decompensation misdiagnosed as a psychotic event.
Higashimoto T; Whitehead MT; MacLeod E; Starin D; Regier DS
Mol Genet Metab Rep; 2022 Sep; 32():100886. PubMed ID: 35756860
[TBL] [Abstract][Full Text] [Related]
9. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
10. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
[TBL] [Abstract][Full Text] [Related]
11. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
[TBL] [Abstract][Full Text] [Related]
12. Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.
Wang XL; Li CJ; Xing Y; Yang YH; Jia JP
J Inherit Metab Dis; 2015 Sep; 38(5):855-61. PubMed ID: 25653144
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
[TBL] [Abstract][Full Text] [Related]
14. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
Schadewaldt P; Hammen HW; Ott AC; Wendel U
J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
[TBL] [Abstract][Full Text] [Related]
15. EEG Pattern in Neonatal Maple Syrup Urine Disease: Description and Clinical Significance.
Poothrikovil RP; Al Thihli K; Al Futaisi A
Neurodiagn J; 2021 Sep; 61(3):123-131. PubMed ID: 34449278
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy in an adolescent with maple syrup urine disease: Case report.
Abadingo ME; Abacan MAR; Basas JRU; Padilla CD
Mol Genet Metab Rep; 2021 Jun; 27():100745. PubMed ID: 33868929
[TBL] [Abstract][Full Text] [Related]
18. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
[TBL] [Abstract][Full Text] [Related]
19. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
Xu J; Jakher Y; Ahrens-Nicklas RC
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
[TBL] [Abstract][Full Text] [Related]
20. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
Skaper SD; Molden DP; Seegmiller JE
Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
